In primary CRC, germline mutations in MMR genes were detected in 24% of patients (8% in MLH1, 7% in MSH6, 5% in MSH2, and 4% in PMS2), while only 18% of tumors were MSI-H [50]. This evidence concerns the gene MRC1 and colorectal carcinoma.